Author

Qingqing Dong

Wenzhou Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Bingjie YuiD· 1 shared Chao LüiD· 1 shared Huan WangiD· 1 shared Jiaying Ma· 1 shared Joshua BandaiD· 1 shared Le Li· 1 shared Ming‐Hua ZhengiD· 1 shared Panyu ZhangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Bingjie YuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hepatocyte FGFR2 Mediates the Antifibrotic Effects of FGF10 in Advanced Liver Fibrosis.

Xuanxin Yang, Bingjie Yu, Jiaying Ma, Yawei Yan, Huan Wang, Qingqing Dong, Shuangyan Peng, Qiqi Wu, Tingting Zhang, Panyu Zhang, Zelong Jiang, Chao Lü, Le Li, Xinyi You, Yuandong Xu, , Xiaojie Wang

This study identifies the hepatocyte FGF10-FGFR2 axis as a negative regulator of fibrogenesis, showing it can attenuate and reverse advanced liver fibrosis.

bioRxiv · Nov 18, 2025 · PreprintPharmacology & Toxicology